Compare MPLT & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | AIN |
|---|---|---|
| Founded | 2018 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2025 | 1994 |
| Metric | MPLT | AIN |
|---|---|---|
| Price | $7.78 | $60.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | $26.54 | ★ $67.67 |
| AVG Volume (30 Days) | ★ 420.3K | 205.9K |
| Earning Date | 12-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 82.39 | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $1,054,132,000.00 |
| Revenue This Year | N/A | $9.92 |
| Revenue Next Year | N/A | $6.29 |
| P/E Ratio | ★ N/A | $53.52 |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $7.85 | $41.15 |
| 52 Week High | $40.43 | $77.00 |
| Indicator | MPLT | AIN |
|---|---|---|
| Relative Strength Index (RSI) | 22.05 | 48.91 |
| Support Level | N/A | $58.46 |
| Resistance Level | $20.46 | $63.90 |
| Average True Range (ATR) | 0.58 | 1.71 |
| MACD | -0.04 | 0.22 |
| Stochastic Oscillator | 11.14 | 54.49 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.